Menu

• Ask a Health Expert about POLYOMAVIRUS-ASSOCIATED NEPHROPATHY
• Post Your Side Effect related to POLYOMAVIRUS-ASSOCIATED NEPHROPATHY
• POLYOMAVIRUS-ASSOCIATED NEPHROPATHY and FDA Warnings
• POLYOMAVIRUS-ASSOCIATED NEPHROPATHY in Patients Wiki
• Report POLYOMAVIRUS-ASSOCIATED NEPHROPATHY in Drug Side Effect Survey

POLYOMAVIRUS-ASSOCIATED NEPHROPATHY side effect

What is POLYOMAVIRUS-ASSOCIATED NEPHROPATHY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Rituximab Side Effects Report #5580932-1
Consumer or non-health professional from SWEDEN reported RITUXIMAB problem on Dec 21, 2007. Male patient, weighting 192.2 lb, was diagnosed with renal transplant and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: polyomavirus-associated nephropathy, . RITUXIMAB dosage: 700 MG, SINGLE. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISOLONE, DOXAZOSIN, ATENOLOL, ENALAPRIL, FELODIPINE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Tacrolimus Side Effects Report #5601082-1
TACROLIMUS problem was reported by a Physician from GERMANY on Jan 21, 2008. Male patient was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: polyomavirus-associated nephropathy, . TACROLIMUS dosage: 8 MG. During the same period patient was treated with PREDNISONE, DACLIZUMAB, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5490046-7
Consumer or non-health professional from SWEDEN reported RITUXIMAB problem on Oct 09, 2007. Male patient, weighting 192.2 lb, was diagnosed with renal transplant and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: polyomavirus-associated nephropathy, . RITUXIMAB dosage: 700 MG, SINGLE. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISOLONE, DOXAZOSIN MESYLATE, ATENOLOL, ENALAPRIL MALEATE, FELODIPINE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5491220-6
RITUXIMAB problem was reported by a Consumer or non-health professional from SWEDEN on Oct 12, 2007. Male patient, weighting 184.1 lb, was diagnosed with renal transplant and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: polyomavirus-associated nephropathy, . RITUXIMAB dosage: 800 MG, SINGLE. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PREDNISOLONE, FUROSEMIDE, METOPROLOL, FELODIPINE. Patient was hospitalized. Patient recovered.


Cellcept Side Effects Report #5467179-4
Physician from GERMANY reported CELLCEPT problem on Sept 14, 2007. Male patient, 61 years of age, weighting 190.7 lb, was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: polyomavirus-associated nephropathy, . CELLCEPT dosage: unknown. During the same period patient was treated with VALGANCICLOVIR, SANDIMMUNE, PRIMAXIN, DECORTIN, TORSEMIDE. Patient was hospitalized. Patient recovered.

Mycophenolate Side Effects Report #5471286-X
MYCOPHENOLATE MOFETIL problem was reported by a Health Professional from JAPAN on Sept 17, 2007. Female patient, 27 years of age, was diagnosed with immunosuppression and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: polyomavirus-associated nephropathy, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, INTRAVENOUS TACROLIMUS, PREDNISONE. Patient recovered.

Azathioprine Side Effects Report #5747236-5
Health Professional from JAPAN reported AZATHIOPRINE problem on May 01, 2008. Male patient, 28 years of age, was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: kidney transplant rejection, polyomavirus-associated nephropathy, . AZATHIOPRINE dosage: 50 MG; QD; PO. During the same period patient was treated with TACROLIMUS, PREDNISOLONE, METHYLPREDNISOLONE, SPARGARIN, MIZORIBINE. Patient recovered.

Prograf Side Effects Report #5326521-5
PROGRAF problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Male patient, 57 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, polyomavirus-associated nephropathy, . PROGRAF dosage: 7 MG, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PEPCID, NORVASC, HYDRALAZINE, LIPITOR, VIAGRA. Patient was hospitalized. Patient recovered.

Basiliximab Side Effects Report #5625984-5
Consumer or non-health professional from reported BASILIXIMAB problem on Feb 06, 2008. Male patient, 38 years of age, was diagnosed with renal transplant and was treated with BASILIXIMAB. After drug was administered, patient experienced the following problems/side effects: chronic allograft nephropathy, kidney transplant rejection, polyomavirus-associated nephropathy, . BASILIXIMAB dosage: 20 MG, UNK. During the same period patient was treated with PROGRAF, CELLCEPT, METHYLPREDNISOLONE. Patient recovered.